Alexza Pharmaceuticals, Inc.

Quick facts

Marketed products

• Inhaled loxapine 10 mg
• Placebo IM
  Placebo IM is an inert substance administered by intramuscular injection that produces no pharmacological effect.

Phase 3 pipeline

• Inhaled Loxapine · Psychiatry
  Inhaled loxapine is a rapid-acting antipsychotic that blocks dopamine and serotonin receptors in the brain to reduce acute agitation.

Phase 2 pipeline

• C=Inhaled Alprazolam 1 m · Neurology
  Alprazolam acts as a positive allosteric modulator of the GABAA receptor, enhancing the inhibitory effects of GABA in the central nervous system.
• IV doxapram · Respiratory
  Stimulates the central nervous system to increase respiratory rate
• Staccato Loxapine

Phase 1 pipeline

• Alprazolam thermal aerosol
• Inhaled prochlorperazine 5 mg
• Intravenous Fentanyl 25 mcg

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Alexza Pharmaceuticals, Inc. portfolio CI brief
• Alexza Pharmaceuticals, Inc. pipeline updates RSS